Global Recombinant Vaccines Sales Market Report 2021

Publisher Name :
Date: 14-May-2021
No. of pages: 120
Inquire Before Buying

The global Recombinant Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Subunit Recombinant Vaccines

- Attenuated Recombinant Vaccines

- Vector Recombinant Vaccines

Segment by Application

- Recombinant Human Vaccines

- Animal Recombinant Vaccines

The Recombinant Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Recombinant Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Merck & Co., Inc

- Green Cross Corporation

- Pfizer Inc.

- Bayer AG

- Sanofi S A.

- Protein Science Corporation

- GlaxoSmithKline Plc.

- Novartis AG

- Bharat Biotech

Global Recombinant Vaccines Sales Market Report 2021

Table of Contents
1 Recombinant Vaccines Market Overview
1.1 Recombinant Vaccines Product Scope
1.2 Recombinant Vaccines Segment by Type
1.2.1 Global Recombinant Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Subunit Recombinant Vaccines
1.2.3 Attenuated Recombinant Vaccines
1.2.4 Vector Recombinant Vaccines
1.3 Recombinant Vaccines Segment by Application
1.3.1 Global Recombinant Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Recombinant Human Vaccines
1.3.3 Animal Recombinant Vaccines
1.4 Recombinant Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Recombinant Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Recombinant Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Recombinant Vaccines Price Trends (2016-2027)
2 Recombinant Vaccines Estimates and Forecasts by Region
2.1 Global Recombinant Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Recombinant Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Recombinant Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Recombinant Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Recombinant Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Recombinant Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Recombinant Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Recombinant Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Recombinant Vaccines Estimates and Projections (2016-2027)
2.4.3 China Recombinant Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Recombinant Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Recombinant Vaccines Estimates and Projections (2016-2027)
2.4.6 India Recombinant Vaccines Estimates and Projections (2016-2027)
3 Global Recombinant Vaccines Competition Landscape by Players
3.1 Global Top Recombinant Vaccines Players by Sales (2016-2021)
3.2 Global Top Recombinant Vaccines Players by Revenue (2016-2021)
3.3 Global Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Vaccines as of 2020)
3.4 Global Recombinant Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Recombinant Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Vaccines Market Size by Type
4.1 Global Recombinant Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Recombinant Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Recombinant Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Recombinant Vaccines Price by Type (2016-2021)
4.2 Global Recombinant Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Recombinant Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Recombinant Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Recombinant Vaccines Price Forecast by Type (2022-2027)
5 Global Recombinant Vaccines Market Size by Application
5.1 Global Recombinant Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Recombinant Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Recombinant Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Recombinant Vaccines Price by Application (2016-2021)
5.2 Global Recombinant Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Recombinant Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Recombinant Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Recombinant Vaccines Price Forecast by Application (2022-2027)
6 North America Recombinant Vaccines Market Facts & Figures
6.1 North America Recombinant Vaccines Sales by Company
6.1.1 North America Recombinant Vaccines Sales by Company (2016-2021)
6.1.2 North America Recombinant Vaccines Revenue by Company (2016-2021)
6.2 North America Recombinant Vaccines Sales Breakdown by Type
6.2.1 North America Recombinant Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Recombinant Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Recombinant Vaccines Sales Breakdown by Application
6.3.1 North America Recombinant Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Recombinant Vaccines Sales Breakdown by Application (2022-2027)
7 Europe Recombinant Vaccines Market Facts & Figures
7.1 Europe Recombinant Vaccines Sales by Company
7.1.1 Europe Recombinant Vaccines Sales by Company (2016-2021)
7.1.2 Europe Recombinant Vaccines Revenue by Company (2016-2021)
7.2 Europe Recombinant Vaccines Sales Breakdown by Type
7.2.1 Europe Recombinant Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Recombinant Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Recombinant Vaccines Sales Breakdown by Application
7.3.1 Europe 120 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 120 Sales Breakdown by Application (2022-2027)
8 China Recombinant Vaccines Market Facts & Figures
8.1 China Recombinant Vaccines Sales by Company
8.1.1 China Recombinant Vaccines Sales by Company (2016-2021)
8.1.2 China Recombinant Vaccines Revenue by Company (2016-2021)
8.2 China Recombinant Vaccines Sales Breakdown by Type
8.2.1 China Recombinant Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Recombinant Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Recombinant Vaccines Sales Breakdown by Application
8.3.1 China 141 Sales Breakdown by Application (2016-2021)
8.3.2 China 141 Sales Breakdown by Application (2022-2027)
9 Japan Recombinant Vaccines Market Facts & Figures
9.1 Japan Recombinant Vaccines Sales by Company
9.1.1 Japan Recombinant Vaccines Sales by Company (2016-2021)
9.1.2 Japan Recombinant Vaccines Revenue by Company (2016-2021)
9.2 Japan Recombinant Vaccines Sales Breakdown by Type
9.2.1 Japan Recombinant Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Recombinant Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Recombinant Vaccines Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Recombinant Vaccines Market Facts & Figures
10.1 Southeast Asia Recombinant Vaccines Sales by Company
10.1.1 Southeast Asia Recombinant Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Recombinant Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Recombinant Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Recombinant Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Recombinant Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Recombinant Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Recombinant Vaccines Market Facts & Figures
11.1 India Recombinant Vaccines Sales by Company
11.1.1 India Recombinant Vaccines Sales by Company (2016-2021)
11.1.2 India Recombinant Vaccines Revenue by Company (2016-2021)
11.2 India Recombinant Vaccines Sales Breakdown by Type
11.2.1 India Recombinant Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Recombinant Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Recombinant Vaccines Sales Breakdown by Application
11.3.1 India Recombinant Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Recombinant Vaccines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Recombinant Vaccines Business
12.1 Merck & Co., Inc
12.1.1 Merck & Co., Inc Corporation Information
12.1.2 Merck & Co., Inc Business Overview
12.1.3 Merck & Co., Inc Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck & Co., Inc Recombinant Vaccines Products Offered
12.1.5 Merck & Co., Inc Recent Development
12.2 Green Cross Corporation
12.2.1 Green Cross Corporation Corporation Information
12.2.2 Green Cross Corporation Business Overview
12.2.3 Green Cross Corporation Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Green Cross Corporation Recombinant Vaccines Products Offered
12.2.5 Green Cross Corporation Recent Development
12.3 Pfizer Inc.
12.3.1 Pfizer Inc. Corporation Information
12.3.2 Pfizer Inc. Business Overview
12.3.3 Pfizer Inc. Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Inc. Recombinant Vaccines Products Offered
12.3.5 Pfizer Inc. Recent Development
12.4 Bayer AG
12.4.1 Bayer AG Corporation Information
12.4.2 Bayer AG Business Overview
12.4.3 Bayer AG Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer AG Recombinant Vaccines Products Offered
12.4.5 Bayer AG Recent Development
12.5 Sanofi S A.
12.5.1 Sanofi S A. Corporation Information
12.5.2 Sanofi S A. Business Overview
12.5.3 Sanofi S A. Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sanofi S A. Recombinant Vaccines Products Offered
12.5.5 Sanofi S A. Recent Development
12.6 Protein Science Corporation
12.6.1 Protein Science Corporation Corporation Information
12.6.2 Protein Science Corporation Business Overview
12.6.3 Protein Science Corporation Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Protein Science Corporation Recombinant Vaccines Products Offered
12.6.5 Protein Science Corporation Recent Development
12.7 GlaxoSmithKline Plc.
12.7.1 GlaxoSmithKline Plc. Corporation Information
12.7.2 GlaxoSmithKline Plc. Business Overview
12.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GlaxoSmithKline Plc. Recombinant Vaccines Products Offered
12.7.5 GlaxoSmithKline Plc. Recent Development
12.8 Novartis AG
12.8.1 Novartis AG Corporation Information
12.8.2 Novartis AG Business Overview
12.8.3 Novartis AG Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis AG Recombinant Vaccines Products Offered
12.8.5 Novartis AG Recent Development
12.9 Bharat Biotech
12.9.1 Bharat Biotech Corporation Information
12.9.2 Bharat Biotech Business Overview
12.9.3 Bharat Biotech Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bharat Biotech Recombinant Vaccines Products Offered
12.9.5 Bharat Biotech Recent Development
13 Recombinant Vaccines Manufacturing Cost Analysis
13.1 Recombinant Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Vaccines
13.4 Recombinant Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Vaccines Distributors List
14.3 Recombinant Vaccines Customers
15 Market Dynamics
15.1 Recombinant Vaccines Market Trends
15.2 Recombinant Vaccines Drivers
15.3 Recombinant Vaccines Market Challenges
15.4 Recombinant Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Recombinant Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Recombinant Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Recombinant Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Recombinant Vaccines Sales (K Units) by Region (2016-2021)
Table 5. Global Recombinant Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Recombinant Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Recombinant Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Recombinant Vaccines Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Recombinant Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Recombinant Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Recombinant Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Recombinant Vaccines Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Recombinant Vaccines Sales Share by Company (2016-2021)
Table 14. Global Recombinant Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Recombinant Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Recombinant Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Vaccines as of 2020)
Table 17. Global Recombinant Vaccines Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Recombinant Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Recombinant Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Recombinant Vaccines Sales (K Units) by Type (2016-2021)
Table 22. Global Recombinant Vaccines Sales Share by Type (2016-2021)
Table 23. Global Recombinant Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Recombinant Vaccines Price (USD/Unit) by Type (2016-2021)
Table 25. Global Recombinant Vaccines Sales Share by Type (2022-2027)
Table 26. Global Recombinant Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Recombinant Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Recombinant Vaccines Price (USD/Unit) by Type (2022-2027)
Table 29. Global Recombinant Vaccines Sales (K Units) by Application (2016-2021)
Table 30. Global Recombinant Vaccines Sales Share by Application (2016-2021)
Table 31. Global Recombinant Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Recombinant Vaccines Price (USD/Unit) by Application (2016-2021)
Table 33. Global Recombinant Vaccines Sales (K Units) by Application (2022-2027)
Table 34. Global Recombinant Vaccines Sales Share by Application (2022-2027)
Table 35. Global Recombinant Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Recombinant Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Recombinant Vaccines Price (USD/Unit) by Application (2022-2027)
Table 38. North America Recombinant Vaccines Sales (K Units) by Company (2016-2021)
Table 39. North America Recombinant Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Recombinant Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Recombinant Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Recombinant Vaccines Sales by Type (2016-2021) & (K Units)
Table 43. North America Recombinant Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Recombinant Vaccines Sales by Type (2022-2027) & (K Units)
Table 45. North America Recombinant Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Recombinant Vaccines Sales by Application (2016-2021) & (K Units)
Table 47. North America Recombinant Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Recombinant Vaccines Sales by Application (2022-2027) & (K Units)
Table 49. North America Recombinant Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Recombinant Vaccines Sales (K Units) by Company (2016-2021)
Table 51. Europe Recombinant Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Recombinant Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Recombinant Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Recombinant Vaccines Sales by Type (2016-2021) & (K Units)
Table 55. Europe Recombinant Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Recombinant Vaccines Sales by Type (2022-2027) & (K Units)
Table 57. Europe Recombinant Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Recombinant Vaccines Sales by Application (2016-2021) & (K Units)
Table 59. Europe Recombinant Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Recombinant Vaccines Sales by Application (2022-2027) & (K Units)
Table 61. Europe Recombinant Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Recombinant Vaccines Sales (K Units) by Company (2016-2021)
Table 63. China Recombinant Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Recombinant Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Recombinant Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Recombinant Vaccines Sales by Type (2016-2021) & (K Units)
Table 67. China Recombinant Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Recombinant Vaccines Sales by Type (2022-2027) & (K Units)
Table 69. China Recombinant Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Recombinant Vaccines Sales by Application (2016-2021) & (K Units)
Table 71. China Recombinant Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Recombinant Vaccines Sales by Application (2022-2027) & (K Units)
Table 73. China Recombinant Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Recombinant Vaccines Sales (K Units) by Company (2016-2021)
Table 75. Japan Recombinant Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Recombinant Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Recombinant Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Recombinant Vaccines Sales by Type (2016-2021) & (K Units)
Table 79. Japan Recombinant Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Recombinant Vaccines Sales by Type (2022-2027) & (K Units)
Table 81. Japan Recombinant Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Recombinant Vaccines Sales by Application (2016-2021) & (K Units)
Table 83. Japan Recombinant Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Recombinant Vaccines Sales by Application (2022-2027) & (K Units)
Table 85. Japan Recombinant Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Recombinant Vaccines Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Recombinant Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Recombinant Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Recombinant Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Recombinant Vaccines Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Recombinant Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Recombinant Vaccines Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Recombinant Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Recombinant Vaccines Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Recombinant Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Recombinant Vaccines Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Recombinant Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Recombinant Vaccines Sales (K Units) by Company (2016-2021)
Table 99. India Recombinant Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Recombinant Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Recombinant Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Recombinant Vaccines Sales by Type (2016-2021) & (K Units)
Table 103. India Recombinant Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Recombinant Vaccines Sales by Type (2022-2027) & (K Units)
Table 105. India Recombinant Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Recombinant Vaccines Sales by Application (2016-2021) & (K Units)
Table 107. India Recombinant Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Recombinant Vaccines Sales by Application (2022-2027) & (K Units)
Table 109. India Recombinant Vaccines Sales Market Share by Application (2022-2027)
Table 110. Merck & Co., Inc Corporation Information
Table 111. Merck & Co., Inc Description and Business Overview
Table 112. Merck & Co., Inc Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Merck & Co., Inc Recombinant Vaccines Product
Table 114. Merck & Co., Inc Recent Development
Table 115. Green Cross Corporation Corporation Information
Table 116. Green Cross Corporation Description and Business Overview
Table 117. Green Cross Corporation Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Green Cross Corporation Recombinant Vaccines Product
Table 119. Green Cross Corporation Recent Development
Table 120. Pfizer Inc. Corporation Information
Table 121. Pfizer Inc. Description and Business Overview
Table 122. Pfizer Inc. Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Pfizer Inc. Recombinant Vaccines Product
Table 124. Pfizer Inc. Recent Development
Table 125. Bayer AG Corporation Information
Table 126. Bayer AG Description and Business Overview
Table 127. Bayer AG Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Bayer AG Recombinant Vaccines Product
Table 129. Bayer AG Recent Development
Table 130. Sanofi S A. Corporation Information
Table 131. Sanofi S A. Description and Business Overview
Table 132. Sanofi S A. Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Sanofi S A. Recombinant Vaccines Product
Table 134. Sanofi S A. Recent Development
Table 135. Protein Science Corporation Corporation Information
Table 136. Protein Science Corporation Description and Business Overview
Table 137. Protein Science Corporation Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Protein Science Corporation Recombinant Vaccines Product
Table 139. Protein Science Corporation Recent Development
Table 140. GlaxoSmithKline Plc. Corporation Information
Table 141. GlaxoSmithKline Plc. Description and Business Overview
Table 142. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. GlaxoSmithKline Plc. Recombinant Vaccines Product
Table 144. GlaxoSmithKline Plc. Recent Development
Table 145. Novartis AG Corporation Information
Table 146. Novartis AG Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Novartis AG Description and Business Overview
Table 148. Novartis AG Recombinant Vaccines Product
Table 149. Novartis AG Recent Development
Table 150. Bharat Biotech Corporation Information
Table 151. Bharat Biotech Recombinant Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Bharat Biotech Description and Business Overview
Table 153. Bharat Biotech Recombinant Vaccines Product
Table 154. Bharat Biotech Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Recombinant Vaccines Distributors List
Table 158. Recombinant Vaccines Customers List
Table 159. Recombinant Vaccines Market Trends
Table 160. Recombinant Vaccines Market Drivers
Table 161. Recombinant Vaccines Market Challenges
Table 162. Recombinant Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Vaccines Product Picture
Figure 2. Global Recombinant Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Subunit Recombinant Vaccines Product Picture
Figure 4. Attenuated Recombinant Vaccines Product Picture
Figure 5. Vector Recombinant Vaccines Product Picture
Figure 6. Global Recombinant Vaccines Sales Market Share by Application in 2021 & 2027
Figure 7. Recombinant Human Vaccines Examples
Figure 8. Animal Recombinant Vaccines Examples
Figure 9. Global Recombinant Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Recombinant Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Recombinant Vaccines Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Recombinant Vaccines Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Recombinant Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Recombinant Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Recombinant Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Recombinant Vaccines Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Recombinant Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Recombinant Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Recombinant Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Recombinant Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Recombinant Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Recombinant Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Recombinant Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Recombinant Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Recombinant Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Recombinant Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Recombinant Vaccines Players Market Share by Revenue in Recombinant Vaccines: 2016 & 2020
Figure 28. Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Recombinant Vaccines Revenue Share by Type (2016-2021)
Figure 30. Global Recombinant Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Recombinant Vaccines Revenue Share by Application (2016-2021)
Figure 32. Global Recombinant Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Recombinant Vaccines Sales Market Share by Type in 2020
Figure 34. North America Recombinant Vaccines Sales Market Share by Application in 2020
Figure 35. Europe Recombinant Vaccines Sales Market Share by Type in 2020
Figure 36. Europe Recombinant Vaccines Sales Market Share by Application in 2020
Figure 37. China Recombinant Vaccines Sales Market Share by Type in 2020
Figure 38. China Recombinant Vaccines Sales Market Share by Application in 2020
Figure 39. Japan Recombinant Vaccines Sales Market Share by Type in 2020
Figure 40. Japan Recombinant Vaccines Sales Market Share by Application in 2020
Figure 41. Southeast Asia Recombinant Vaccines Sales Market Share by Type in 2020
Figure 42. Southeast Asia Recombinant Vaccines Sales Market Share by Application in 2020
Figure 43. India Recombinant Vaccines Sales Market Share by Type in 2020
Figure 44. India Recombinant Vaccines Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Recombinant Vaccines
Figure 47. Manufacturing Process Analysis of Recombinant Vaccines
Figure 48. Recombinant Vaccines Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
  • Global Lidocaine Patches Sales Market Report 2021
    Published: 14-Jun-2021        Price: US 4000 Onwards        Pages: 136
    Lidocaine patches are used to relieve the pain of post-herpetic neuralgia (PHN; the burning, stabbing pains, or aches that may last for months or years after a shingles infection). Lidocaine is in a class of medications called local anesthetics. It works by stopping nerves from sending pain signals. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends i......
  • Global Injectables Market: Insights & Forecast with Potential Impact of COVID-19 (2021-2025)
    Published: 14-Jun-2021        Price: US 1800 Onwards        Pages: 127
    The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive the growth of the market. However, the market growth would be challenged by stringent regulatory guidelines, emergence of alternative drug delivery metho......
  • Global Clenbuterol Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 14-Jun-2021        Price: US 3480 Onwards        Pages: 105
    The Clenbuterol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest research, t......
  • Global Antacid Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 113
    Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. The global average price of Antacid is in the decreasing trend, from 11.43 USD/Unit in 2013 to 10.73 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following fiv......
  • Global Codeine Phosphate Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 145
    Codeine Phosphate is a type of medicine called an opioid. Codeine is a mild painkiller, but also has cough suppressant and anti-diarrhoeal actions. In the last several years, global market of Codeine Phosphate developed with the production growth rate of 6%. In 2015, global capacity of Codeine Phosphate was more than 400 MT. Market Analysis and Insights: Global Codeine Phosphate Market The global Codeine Phosphate market is valued at US$ 202.2 million in 2019. The ma......
  • Global Clenbuterol Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 149
    The global Clenbuterol market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clenbuterol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Tablets - Films - Aerosol - Other......
  • Global Human Vaccine Market Insights and Forecast to 2027
    Published: 10-Jun-2021        Price: US 4900 Onwards        Pages: 149
    Human Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Varicella - Influenza - Polio - Hepatitis A - Rabies - BCG - Hepatitis B......
  • Global Sildenafil Citrate Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 10-Jun-2021        Price: US 3480 Onwards        Pages: 102
    The Sildenafil Citrate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest rese......
  • Minoxidil: Global Markets
    Published: 09-Jun-2021        Price: US 3950 Onwards        Pages: 58
    Report Scope The report analyzes the market trends of Minoxidil with data from 2019, estimates from 2020, and projections of compound annual growth rates (CAGRs) through the forecast period of 2020 through 2025). The report will highlight the current and future market potential of Minoxidil along with an analysis of the competitive landscape. Regulatory scenarios, drivers, restraints, and opportunities are covered. For this report, the market is segmented based on......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs